In the European summer of 2027, the world faces a threat, not only to human health but also to biological diversity and food security. An alarming scenario is emerging: The rapidly thawing permafrost in the Russian tundra has released an unknown form of anthrax that is primarily transmitted by...

The "One Health" approach has found its way into political processes at various levels. The reason for this is the increased occurrence of zoonoses, i.e. infectious diseases that can be reciprocally transmitted between animals and humans. One Health is located at the intersection of human,...

Im Aufbau einer neuen globalen Gesundheitsarchitektur nach der Covid-19-Pandemie stehen wichtige Weichenstellungen an, insbesondere bei der Verhandlung des Pande­mie­abkommens und der Schaffung robuster Lieferketten. Vor dem Hintergrund ihrer systemischen Rivalität betrachten die USA und...

The development of a new global health architecture in the wake of Covid-19 will require important decisions to be made, especially when it comes to negotiating a pandemic accord and creating robust supply chains. Against the backdrop of their systemic rivalry, the US and China view global...

Die globale Gesundheitsstrategie der Europäischen Union (EU) von November 2022 zielt auf eine offene strategische Autonomie im Arzneimittelsektor. Dies wird zwangsläufig zu einer Neugestaltung sowohl der Liefer- und Wertschöpfungsketten der EU als auch ihrer Handelsbeziehungen führen. Das...

The European Union's (EU) Global Health Strategy calls for open and strategic autonomy in the field of pharmaceuticals, which would lead to the redesign of EU global supply and value chains as well as trade relations. As the EU and Germany are seeking to diversify their trade partners, the...

Die globale Gesundheitsstrategie der Europäischen Union (EU) von November 2022 zielt auf eine offene strategische Autonomie im Arzneimittelsektor. Dies wird zwangsläufig zu einer Neugestaltung sowohl der Liefer- und Wertschöpfungsketten der EU als auch ihrer Handelsbeziehungen führen. Das...

The European Union’s (EU) Global Health Strategy calls for open and strategic autonomy in the field of pharmaceuticals, which would lead to the redesign of EU global supply and value chains as well as trade relations. As the EU and Germany are seeking to diversify their trade partners, the...

Im Aufbau einer neuen globalen Gesundheitsarchitektur nach der Covid-19-Pandemie stehen wichtige Weichenstellungen an, insbesondere bei der Verhandlung des Pande­mie­abkommens und der Schaffung robuster Lieferketten. Vor dem Hintergrund ihrer systemischen Rivalität betrachten die USA und...

The development of a new global health architecture in the wake of Covid-19 will require important decisions to be made, especially when it comes to negotiating a pandemic accord and creating robust supply chains. Against the backdrop of their systemic rivalry, the US and China view global...